UK markets open in 7 hours 2 minutes
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.82 +0.01 (+0.01%) GOLD FUTURES
2,328.50 -9.90 (-0.42%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,575.93 -1,717.11 (-3.22%)
JCR Pharmaceuticals Co., Ltd. (4552.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 808.00 |
| Open | 809.00 |
| Bid | 0.00 x 0 |
| Ask | 812.00 x 0 |
| Day's range | 809.00 - 822.00 |
| 52-week range | 778.00 - 1,567.00 |
| Volume | |
| Avg. volume | 759,055 |
| Market cap | 101.463B |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 19.01 |
| EPS (TTM) | 42.76 |
| Earnings date | 10 May 2024 |
| Forward dividend & yield | 20.00 (2.46%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 1,700.00 |
Business WireJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
Business WireJCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
Business WireJCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.
© 2024 Yahoo. All rights reserved.